Avastin, the new drug developed for the treatment of several types of cancer has finally been approved for the treatment of cervical cancer in combination with chemotherapy by the Food and Drug Administration. Avastin (containing bevacizumab, monoclonal antibodies)is an angiogenesis inhibitor. It slows the development of new blood vessels that form in and feed tumors. While bevacizumab is … [Read more...]
FDA Oversight Granted to Genetic Testing for Therapy Match-Making
Up till now, genetic tests that would predict diseases or match cancer patients to appropriate therapies or drugs haven’t been strictly regulated by the FDA. A proposal issued on Thursday has stated that these tests should be attentively regulated by the Food and Drug Administration. What the proposal suggested is that the FDA would review all tests in advance for genetic mutations so as to be … [Read more...]